89bio, Inc.
ETNB
$9.59
$0.374.01%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 28.97M | 27.66M | 24.57M | 22.41M | 21.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 151.20M | 135.36M | 123.06M | 105.67M | 102.25M |
| Operating Income | -151.20M | -135.36M | -123.06M | -105.67M | -102.25M |
| Income Before Tax | -138.32M | -126.54M | -118.62M | -105.28M | -102.01M |
| Income Tax Expenses | 3.87M | 16.00K | 18.00K | 18.00K | 19.00K |
| Earnings from Continuing Operations | -142.19 | -126.56 | -118.64 | -105.30 | -102.03 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -142.19M | -126.56M | -118.64M | -105.30M | -102.03M |
| EBIT | -151.20M | -135.36M | -123.06M | -105.67M | -102.25M |
| EBITDA | -151.15M | -135.31M | -123.00M | -105.60M | -102.18M |
| EPS Basic | -2.01 | -2.00 | -2.11 | -2.82 | -3.54 |
| Normalized Basic EPS | -1.26 | -1.27 | -1.34 | -1.79 | -2.22 |
| EPS Diluted | -2.01 | -2.00 | -2.11 | -2.82 | -3.54 |
| Normalized Diluted EPS | -1.26 | -1.27 | -1.34 | -1.79 | -2.22 |
| Average Basic Shares Outstanding | 284.33M | 254.44M | 225.36M | 171.59M | 138.75M |
| Average Diluted Shares Outstanding | 284.33M | 254.44M | 225.36M | 171.59M | 138.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
